Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Teva Pharma Industries Ltd ADR

TEVA
Current price
17.96 USD +0.36 USD (+2.05%)
Last closed 17.52 USD
ISIN US8816242098
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NYSE
Capitalization 21 455 536 128 USD
Yield for 12 month +79.06 %
1Y
3Y
5Y
10Y
15Y
TEVA
21.11.2021 - 28.11.2021

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; GRANIX; TRISENOX; LONQUEX; and TEVAGRASTIM/RATIOGRASTIM. In addition, it provides COPAXONE for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR for treatment for asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax, an inhaled corticosteroid and long-acting beta-agonist bronchodilator; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel. Address: 124 Dvora HaNevi?a Street, Tel Aviv, Israel, 6944020

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

21.14 USD

P/E ratio

Dividend Yield

Current Year

+15 846 000 000 USD

Last Year

+14 925 000 000 USD

Current Quarter

+4 162 000 000 USD

Last Quarter

+3 832 000 000 USD

Current Year

+7 645 000 000 USD

Last Year

+6 973 000 000 USD

Current Quarter

+2 022 000 000 USD

Last Quarter

+1 784 000 000 USD

Key Figures TEVA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 4 565 000 192 USD
Operating Margin TTM 19.62 %
PE Ratio
Return On Assets TTM 5.16 %
PEG Ratio 1.2934
Return On Equity TTM -10.51 %
Wall Street Target Price 21.14 USD
Revenue TTM 16 289 999 872 USD
Book Value 5.61 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 7.4 %
Dividend Yield
Gross Profit TTM 6 973 000 000 USD
Earnings per share -0.39 USD
Diluted Eps TTM -0.39 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 40 %
Profit Margin -2.78 %

Dividend Analytics TEVA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History TEVA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 27.11.2017
Forward Annual Dividend Yield
Last Split Factor 2:1
Payout Ratio
Last Split Date 01.07.2004
Dividend Date 12.12.2017

Stock Valuation TEVA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 6.8353
Enterprise Value Revenue 2.2779
Price Sales TTM 1.3171
Enterprise Value EBITDA 19.2256
Price Book MRQ 3.2211

Financials TEVA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators TEVA

For 52 weeks

8.06 USD 19.08 USD
50 Day MA 17.35 USD
Shares Short Prior Month 17 681 618
200 Day MA 14.27 USD
Short Ratio 2.35
Shares Short 23 994 752
Short Percent 2.13 %

Dynamics of changes in the value of assets

G

G84

127.50 EUR GENERAC HLDGS 0 (0%)
Detailed analytics
E

ESSITY-B

320.10 SEK Essity AB (publ) -0.02 (-0.06%)
Detailed analytics
W

WX5

147.00 EUR George Weston Limited 0 (0%)
Detailed analytics
K

KSF1

37.40 EUR SHINHAN FINL ADR/1 SW5000 +0.22 (+0.54%)
Detailed analytics
E

EBKDY

26.24 USD Erste Group Bank AG PK -0.25 (-0.94%)
Detailed analytics